Virobay Inc. and LEO Pharma initiated a collaboration in early January 2012 to develop an oral treatment in psoriasis. Link to press release
At Virobay, we are dedicated to moving protease inhibitors forward for the treatment of autoimmune and skin diseases, neuropathic pain, liver diseases and cancer.
Why partner with Virobay
- Our focus is to help patients with debilitating diseases
- We have extensive knowledge and experience designing selective protease inhibitors
- We have decades of experience in drug discovery and development, including leadership roles at Roche, Wellcome, Sugen and Celera Genomics
- We are highly collaborative with partners
- We are a privately held, independent company
For information about our partnership opportunities, please contact the Virobay Business Development Department.
Attn: Business Development
1490 O’Brien Drive, Suite G
Menlo Park, CA 94025